Robert T. Goegelman

Statistics

Publications

Citations

1.1K

H-Index

Active since

1970

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD K.K. (Japan)

Robert T. Goegelman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and life sciences.

Publications per year

1970–1992

Publications

Thienamycin, a new .BETA.-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

Jean S. Kahan, Frederick M. Kahan, Robert T. Goegelman et al. · The Journal of Antibiotics · 1979 · 507 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Avermectins, New Family of Potent Anthelmintic Agents: Isolation and Chromatographic Properties

Thomas W. Miller, Louis Chaiet, Douglas J. Cole et al. · Antimicrobial Agents and Chemotherapy · 1979 · 179 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +13

Novel antinematodal and antiparasitic agents from Penicillium charlesii. I. Fermentation, isolation and biological activity.

John G. Ondeyka, Robert T. Goegelman, James M. Schaeffer et al. · The Journal of Antibiotics · 1990 · 118 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Studies on the structures of imipenem, dehydropeptidase I-hydrolyzed imipenem, and related analogs

Ronald W. Ratcliffe, Kenneth J. Wildonger, Lisa Di Michele et al. · The Journal of Organic Chemistry · 1989 · 51 citations

Life Sciences, Chemistry, Pharmacology +6

[3H]Paraherquamide binding to caenorhabditis elegans

James M. Schaeffer, Timothy A. Blizzard, John G. Ondeyka et al. · Biochemical Pharmacology · 1992 · 49 citations

Medicine, Molecular Biology, Pharmacology +8

1–5 of 12